Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C46H58ClN5O8 |
| Molecular Weight | 844.434 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CCOC(=O)CC2=C(C)N(C(=O)C3=CC=C(Cl)C=C3)C4=C2C=C(OC)C=C4)CC1)NC(=O)C5=CC=CC=C5
InChI
InChIKey=PTXGHCGBYMQQIG-UHFFFAOYSA-N
InChI=1S/C46H58ClN5O8/c1-5-21-51(22-6-2)46(57)40(48-44(55)34-11-8-7-9-12-34)18-20-42(53)59-29-10-23-49-24-26-50(27-25-49)28-30-60-43(54)32-38-33(3)52(41-19-17-37(58-4)31-39(38)41)45(56)35-13-15-36(47)16-14-35/h7-9,11-17,19,31,40H,5-6,10,18,20-30,32H2,1-4H3,(H,48,55)
| Molecular Formula | C46H58ClN5O8 |
| Molecular Weight | 844.434 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionCurator's Comment: Description was created based on several sources, including
http://www.druginfosys.com/drug.aspx?drugcode=980&drugname=&type=2
https://www.ncbi.nlm.nih.gov/pubmed/2826180
Curator's Comment: Description was created based on several sources, including
http://www.druginfosys.com/drug.aspx?drugcode=980&drugname=&type=2
https://www.ncbi.nlm.nih.gov/pubmed/2826180
Proglumetacin (usually as the maleate salt, trade names Afloxan, Protaxon and Proxil) is a non-steroidal anti-inflammatory drug. Proglumetacin is indicated for the pain and inflammation associated with musculoskeletal and joint disorders. The action of proglumetacin maleate is qualitatively the same as that of indomethacin in vivo; that is, it inhibits cyclo-oxygenase in inflammatory sites.
Originator
Sources: http://www.google.com/patents/CN103641886B?cl=en
Curator's Comment: first developed by the German company Fresenius
Approval Year
Sample Use Guides
Oral
Pain and inflammation associated with musculoskeletal and joint disorders
Adult: Up to 600 mg/day in divided doses.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3102823
PGM (IC50 = 1.5 uM) strongly inhibited 5-HETE formation by the cytosol of guinea pig polymorphonuclear leukocytes.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:54:20 GMT 2025
by
admin
on
Mon Mar 31 18:54:20 GMT 2025
|
| Record UNII |
FV919079LU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QM01AB14
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
||
|
WHO-ATC |
M01AB14
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m9160
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | Merck Index | ||
|
57132-53-3
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
DTXSID0048842
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105825
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
DB13527
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
34769
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | RxNorm | ||
|
FV919079LU
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
4921
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
76263
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
Proglumetacin
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
2280
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
3977
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
C019541
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
100000091998
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
SUB10077MIG
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY | |||
|
C170354
Created by
admin on Mon Mar 31 18:54:20 GMT 2025 , Edited by admin on Mon Mar 31 18:54:20 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |